Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: A randomized controlled study

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 6, 2001, Pages 843-849

  Wong, B C Y ^a   Wang, W H ^a   Wong, W M ^a   Lau, G K K ^a   Fung, F M Y ^a   Kung, N N S ^c   Chu, K M ^a   Lai, K C ^a   Hu, W H C ^a   Hu, F L ^b   Liu, X G ^b   Chan, C K ^a   Yuen, M F ^a   Hui, W M ^a   Lam, S K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c UNITED CHRISTIAN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH CITRATE; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; DRUG TOLERABILITY; DUODENUM ULCER; ENDOSCOPY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULCER HEALING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; TREATMENT OUTCOME;

EID: 0034982544     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.00999.x     Document Type: Article

References (27)

1. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
2. Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance anti-secretory treatment in the prevention of recurrence of duodenal ulcer: A prospective long-term follow-up study
3. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: An Asian multi-center prospective double blind randomized placebo controlled study
4. A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori
5. 13C-urea breath test without a test meal is highly accurate for the detection of Helicobacter pylori infection in Chinese
6. One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea
7. Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection
8. The efficacy and safety of one-week triple therapy with lansoprazole, and metronidazole for the treatment of Helicobacter pylori infection in Japanese patients
9. Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: A short report
10. One week triple therapy for Helicobacter pylori: A multicentre comparative study
11. In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori)
12. Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state
13. Clarithromycin as mono-therapy for eradication of H. pylori: A randomized, double-blind trial
14. Anti-Helicobacter pylori treatment in bleeding ulcers: Randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy
15. Bismuth-based quadruple therapy for Helicobacter pylori - A single triple capsule plus lansoprazole
16. Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton pump inhibitor-based therapy: A detailed prospective analysis of 21 consecutive cases
17. Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection
18. The ideal therapy must be defined in each geographical area: Experience with a quadruple therapy in Spain
19. 4-day lansoprazole therapy: A highly effective cure for Helicobacter pylori infection
20. Four-day lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infection
21. Four-day quadruple therapy as a routine treatment for Helicobacter pylori infection
22. Two-day 'weekend' lansoprazole-quadruple therapy for Helicobacter pylori infection
23. Two-day quadruple therapy for cure of Helicobacter pylori infection: A comparative, randomized trial
24. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen
25. A three-day octreotide-containing Helicobacter pylori eradication therapy for cure of peptic ulcers
26. One-week triple therapy with omeprazole, amoxycillin, and either clarithromycin or metronidazole for cure of Helicobacter pylori infection
27. Eradication of Helicobacter pylori using one-week triple therapies combined omeprazole with two antimicrobials: The MACH I study